Advanced Prostate Cancer Consensus Conference (APCCC)

9 October 2021
Register NOW
APCCC online
Live moderation by panelists, live voting & “Aperitivo”-Challenge the Experts Sessions
27 April 2022
Translational Prostate Cancer Symposium
28 - 30 April 2022
APCCC
Lugano / Switzerland
Hybrid Conference

APCCC Online 2021 - Scientific Programme APCCC 2019 - report

NOTICE ON APCCC 2021 / 2022

The APC Executive Committee is highly conscientious of the impact that the current COVID-19 pandemic has on travel and event restrictions. We strongly believe in mitigating the spread of the virus while still maintaining the ability to facilitate the exchange between experts, and positively impact the lives of patients with advanced prostate cancer.

Therefore the APCCC 2022 is planned as a hybrid event. We will hold the conference as a face-to-face meeting, while providing the benefits of the conference in an online format. This opens opportunities for attendance to valuable experts from around the world, who may otherwise not be able to attend. Additionally, it provides us the flexibility to move to a completely virtual format, should a face-to-face meeting not be feasible next year.

In addition to the main meeting, there will be a virtual consensus meeting in October 2021 with a live moderation by panelists and a live voting.

Stay Connected

Find below our Twitter-Feed to get the hottest news.
APCCC21

APCCC 2021 Online Consensus Meeting | Live moderation by panelists & live voting 🗓️ Save the date: 9 October 2021 See who will be joining our...

APCCC_Lugano 16 June
APCCC21

#Flashback Tweet from 2 years ago: " @DrMHofman @piet_ost @pezaro_c Let’s hope that the general enthusiasm about PSMA-targeted therapies results in...

APCCC_Lugano 16 June
APCCC21

RT @Silke_Gillessen: Lots of open questions about best use (dose, schedule, duration) of the BPAs. We will discuss and vote again at APCCC…

APCCC_Lugano 16 June
APCCC21

RT @EUplatinum: New Words of Wisdom from @Tilki_De and Christopher P. Evans Re: Regional Adoption of Commercial Gene Expression Testing fo…

APCCC_Lugano 16 June
APCCC21

RT @CancerNetwrk: Almost all patients with nonmetastatic castration-resistant prostate cancer treated on the phase 3 ARAMIS trial were able…

APCCC_Lugano 16 June
APCCC21

RT @MedpageOnco: The use of bone-protecting agents substantially reduced the risk of fracture in these men with castration-resistant #prost…

APCCC_Lugano 16 June